1. Home
  2. EVO vs UDMY Comparison

EVO vs UDMY Comparison

Compare EVO & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • UDMY
  • Stock Information
  • Founded
  • EVO 1993
  • UDMY 2009
  • Country
  • EVO Germany
  • UDMY United States
  • Employees
  • EVO N/A
  • UDMY N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • UDMY Other Consumer Services
  • Sector
  • EVO Health Care
  • UDMY Real Estate
  • Exchange
  • EVO Nasdaq
  • UDMY Nasdaq
  • Market Cap
  • EVO 1.4B
  • UDMY 1.1B
  • IPO Year
  • EVO 2021
  • UDMY 2021
  • Fundamental
  • Price
  • EVO $3.76
  • UDMY $6.94
  • Analyst Decision
  • EVO Buy
  • UDMY Buy
  • Analyst Count
  • EVO 2
  • UDMY 11
  • Target Price
  • EVO $5.90
  • UDMY $10.10
  • AVG Volume (30 Days)
  • EVO 159.9K
  • UDMY 1.0M
  • Earning Date
  • EVO 08-13-2025
  • UDMY 07-30-2025
  • Dividend Yield
  • EVO N/A
  • UDMY N/A
  • EPS Growth
  • EVO N/A
  • UDMY N/A
  • EPS
  • EVO N/A
  • UDMY N/A
  • Revenue
  • EVO $851,944,444.00
  • UDMY $790,019,000.00
  • Revenue This Year
  • EVO $10.08
  • UDMY $1.87
  • Revenue Next Year
  • EVO $10.99
  • UDMY $4.15
  • P/E Ratio
  • EVO N/A
  • UDMY N/A
  • Revenue Growth
  • EVO 1.50
  • UDMY 5.43
  • 52 Week Low
  • EVO $2.84
  • UDMY $5.68
  • 52 Week High
  • EVO $5.64
  • UDMY $10.61
  • Technical
  • Relative Strength Index (RSI)
  • EVO 41.37
  • UDMY 43.44
  • Support Level
  • EVO $4.06
  • UDMY $6.84
  • Resistance Level
  • EVO $4.44
  • UDMY $7.10
  • Average True Range (ATR)
  • EVO 0.11
  • UDMY 0.25
  • MACD
  • EVO -0.04
  • UDMY -0.08
  • Stochastic Oscillator
  • EVO 0.00
  • UDMY 11.11

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

Share on Social Networks: